BeStock  
Stocks › Biotechnology › CYTK

Cytokinetics CYTK

US equityMarket cap rank #1720Biotechnology
$50.78 −$0.68 (-1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $52.48 +3.35%
Open$51.27
Prev close$51.46
Day range$50.60 – $53.45
Volume1.43M
Market cap$7.07B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts16
Average target$107.29+111.3% vs. price
  • Buy 94%
  • Hold 6%
Low $78.00Now $50.78Avg $107.29High $140.00

Recent rating changes

The last 20 actions on file set price targets from $78.00 to $140.00, averaging $109.00.

DateFirmRatingTarget
9 Nov 2026 H.C. Wainwright BUY $140.00
6 Nov 2026 Truist Financial BUY $112.00
6 Nov 2026 Citi BUY $105.00
5 Nov 2026 Wells Fargo BUY $105.00
5 Nov 2026 Piper Sandler BUY $107.00
5 Nov 2026 Morgan Stanley BUY $103.00
5 Nov 2026 Evercore BUY $100.00
5 Nov 2026 Stifel BUY $108.00
5 Nov 2026 Citi BUY $105.00
5 Nov 2026 H.C. Wainwright BUY $140.00
5 Nov 2026 Barclays BUY $110.00
4 Nov 2026 BofA Securities HOLD $78.00
4 Nov 2026 RBC Capital BUY $113.00
3 Nov 2026 Morgan Stanley BUY $103.00
19 Oct 2026 BofA Securities HOLD $81.00
19 Oct 2026 H.C. Wainwright BUY $140.00
15 Oct 2026 William Blair BUY –
15 Oct 2026 UBS BUY $104.00
14 Oct 2026 UBS BUY $104.00
14 Oct 2026 RBC Capital BUY $113.00

Discussion

No comments yet — be the first to weigh in on CYTK.

Sign in to join the discussion.

Scroll to Top